Hence, our study enrolled 381 NSCLC patients to detect the expression of CCT6A in tumor and adjacent tissues and investigated the correlation of tumor CCT6A expression with clinicopathological features and survival profiles in these NSCLC patients. Here, CCT6A is linked to non-small cell lung carcinoma.